Caribbean

Resilience System


You are here

Treatments

Paxlovid cuts hospitalization, death only in COVID patients with weak immune systems -- Canadian study

 

...in JAMA Network Open, an observational Canadian study ties the antiviral drug combo nirmatrelvir-ritonavir (Paxlovid) to a lower risk of hospitalization or death only in very high-risk COVID-19 patients with weakened immune systems.

...

 

 

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Both Paxlovid, molnupiravir lower COVID Omicron deaths, hospitalizations -- studies

Two new studies describe the benefits of the antiviral drugs nirmatrelvir-ritonavir (Paxlovid) and molnupiravir in reducing SARS-CoV-2 Omicron hospitalizations and death, with one finding that the former is more effective than the latter at lowering death rates.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Depressant fluvoxamine not effective in reducing COVID inflammation--study

 

A clinical trial designed to test repurposed medications for their impact on fighting COVID-19 has found no benefit to taking the antidepressant fluvoxamine (Luvox) to ease coronavirus symptoms.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Black cancer patients have much higher rates of COVID hospital stays. according to new study

Race, COVID-19 infections, and chronic disease contributed to higher COVID-related hospitalization rates for Black patients compared to white patients, according to new research from scientists at Louisiana State University (LSU) Health, New Orleans, School of Public Health published in the Journal of the National Cancer Institute.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Pages

Subscribe to Treatments
howdy folks
Page loaded in 0.549 seconds.